Ignite Creation Date:
2024-05-06 @ 1:58 AM
Last Modification Date:
2024-10-26 @ 11:11 AM
Study NCT ID:
NCT01932515
Status:
UNKNOWN
Last Update Posted:
2014-06-26
First Post:
2013-08-27
Brief Title:
Diagnostic Instruments for Autism in Deaf Children Study
Sponsor:
Leeds and York Partnership NHS Foundation Trust
Organization:
Leeds and York Partnership NHS Foundation Trust
Study Overview
Official Title:
Diagnostic Instruments for Autism in Deaf Children Study
Status:
UNKNOWN
Status Verified Date:
2014-06
Last Known Status:
ACTIVE_NOT_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DIADS
Brief Summary:
The trial is in three stages and will translate and validate screening and assessment instruments for use with deaf children
The first stage is modifying the screening and assessment instruments ADI-R and ADOS-2 for use with deaf children This will involve choosing the most promising screening instrument SRS-2 based on the systematic review and the expertise of a review panel which contains experts and public and patient involvement PPI This phase of the study seeks a wide range of user parents carers and young people views and experiences about the symptomatology and presentation of deaf children with autism comparing this to hearing children with autism and deaf children without autism
The second stage is to ensure that the newly modified instruments are accessible to deaf children and deaf parents by making any necessary translations from English into British Sign Language This involves a strict translation and back translation methodology with reiterations until successful translation is achieved
For stage three in order to ensure that the new questionnaires are successfully identifying children and young people with Autism Spectrum Disorder the modified instrument will be validated using a gold standard The current gold standard for the mental health screening of Deaf children is a clinical interview administered by experienced senior multidisciplinary deaf child mental health clinicians
The first stage is modifying the screening and assessment instruments ADI-R and ADOS-2 for use with deaf children This will involve choosing the most promising screening instrument SRS-2 based on the systematic review and the expertise of a review panel which contains experts and public and patient involvement PPI This phase of the study seeks a wide range of user parents carers and young people views and experiences about the symptomatology and presentation of deaf children with autism comparing this to hearing children with autism and deaf children without autism
The second stage is to ensure that the newly modified instruments are accessible to deaf children and deaf parents by making any necessary translations from English into British Sign Language This involves a strict translation and back translation methodology with reiterations until successful translation is achieved
For stage three in order to ensure that the new questionnaires are successfully identifying children and young people with Autism Spectrum Disorder the modified instrument will be validated using a gold standard The current gold standard for the mental health screening of Deaf children is a clinical interview administered by experienced senior multidisciplinary deaf child mental health clinicians
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None